Skip to main content
Przejdź do strony domowej Komisji Europejskiej (odnośnik otworzy się w nowym oknie)
polski pl
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

Investigating the malaria-driven autoimmune imprint of humoral immunity

Cel

Malaria was the strongest selective pressure in recent human evolution, yet its profound impact on our immune system is poorly understood. My recent work showed that high autoantibody (AAb) titers correlate with a 41% reduced risk of febrile malaria. These AAbs inhibit Plasmodium falciparum (Pf) growth and bind Pf invasion proteins. I propose that effective malaria immunity is autoreactive, presenting a paradigm shift where controlled breakdowns in immune tolerance are essential for protection. As tolerance mechanisms limit autoreactive immunity, this may explain the slow acquisition of natural immunity and poor malaria vaccine efficacy. It was suggested that genetic susceptibility to autoimmunity evolved as a survival advantage against malaria, and my data indicate the ability to develop an AAb response was central to this adaptation. Despite genetic susceptibility and elevated AAb titers, individuals in malaria-endemic regions are relatively protected from autoimmune diseases, likely due to an immune environment driven by chronic Pf malaria and other pathogens.
Foundational knowledge, which is now technically within reach, is required to exploit the connection between autoimmune disease and infection immunity, to improve malaria vaccines and transform autoimmune therapies. I propose comparative studies of autoreactive B cells and antibodies in autoimmune disease patients and malaria-exposed individuals, using field studies in Africa and advanced antigen-specific B cell methods, together with mouse models, to address the following key questions: 1) Do immune tolerance mechanisms impair malaria immunity? 2) What defines the immune environment of chronic Pf exposure that protects from autoimmune diseases?
This research will illuminate the genetic and individual imprint shaped by malaria, reveal barriers to effective malaria immunity and uncover immunoregulatory mechanisms in chronic malaria, potentially identifying therapeutic strategies for inflammatory conditions.

Dziedzina nauki (EuroSciVoc)

Słowa kluczowe

Program(-y)

Temat(-y)

System finansowania

HORIZON-ERC - HORIZON ERC Grants

Wyświetl wszystkie projekty finansowane w ramach tego programu finansowania

Zaproszenie do składania wniosków

(odnośnik otworzy się w nowym oknie) ERC-2025-COG

Wyświetl wszystkie projekty finansowane w ramach tego zaproszenia

Instytucja przyjmująca

BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN
Wkład UE netto
€ 1 960 433,00
Koszt całkowity
€ 1 960 433,75

Beneficjenci (1)